Clinic
Yakima Valley Farm Workers Clinic
Yakima Valley Farm Workers Clinic was paid $13.76M by Medicaid between Jan 2018 and Dec 2024, across 173 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoYAKIMA VALLEY FARM WORKERS CLINIC
TOPPENISH, WA 98948
TOPPENISH, WA 98948
33aNPI1083743538assigned 03/02/2007
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$13.76M
24GClaims783,467
24DCodes billed173
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Washington
Rank by total paid#15 of 162
Median peer was paid$704K
This provider vs. median20×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TROTTER, CHRISTINE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 80,748 | $1.28M | |
| 2019 | 89,620 | $1.51M | |
| 2020 | 89,002 | $1.96M | |
| 2021 | 113,816 | $2.55M | |
| 2022 | 105,888 | $2.31M | |
| 2023 | 108,474 | $2.14M | |
| 2024incomplete | 195,919 | $2.02M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 189,059 | 167,318 | $3.36M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.5% | 66,676 | 59,673 | $1.18M |
| G9011 | Coordinated care fee, risk adjusted maintenance, level 5 | 5.2% | 8,390 | 6,925 | $710K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.0% | 9,292 | 9,191 | $683K |
| D0120 | Dental checkup, returning patientPeriodic oral evaluation - established patient | 4.2% | 23,116 | 21,024 | $578K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.4% | 10,222 | 9,510 | $462K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.2% | 9,016 | 8,885 | $446K |
| D1120 | Dental cleaning, childProphylaxis - child | 2.9% | 14,165 | 12,926 | $396K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.7% | 5,180 | 5,115 | $371K |
| D0150 | Comprehensive oral evaluation - new or established patient | 2.5% | 8,461 | 7,330 | $350K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 2.5% | 7,285 | 5,401 | $349K |
| D1110 | Prophylaxis - adult | 2.4% | 8,835 | 7,933 | $324K |
161 more codes
| D1206 | Topical application of fluoride varnish | 2.3% | 26,925 | $323K |
| G9001 | Coordinated care fee, initial rate | 2.2% | 2,432 | $301K |
| 90686 | 1.9% | 21,150 | $257K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 1.8% | 6,989 | $244K |
| D1354 | 1.4% | 16,420 | $192K | |
| D0230 | Intraoral - periapical each additional radiographic image | 1.4% | 36,475 | $186K |
| D0220 | Intraoral - periapical first radiographic image | 1.3% | 22,022 | $185K |
| 90832 | Psychotherapy session, about 30 minutes | 1.2% | 5,536 | $168K |
| D0140 | Limited oral evaluation - problem focused | 1.2% | 4,783 | $164K |
| D1351 | Sealant - per tooth | 1.0% | 8,160 | $140K |
| D0330 | Panoramic radiographic image | <1% | 6,275 | $130K |
| D0274 | Bitewings - four radiographic images | <1% | 9,907 | $118K |
| G9012 | Other specified case management service not elsewhere classified | <1% | 2,173 | $107K |
| 90688 | <1% | 8,535 | $103K | |
| 90670 | <1% | 6,015 | $99K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 1,034 | $85K |
| D0272 | Bitewings - two radiographic images | <1% | 7,241 | $77K |
| D4910 | <1% | 2,306 | $74K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 15,701 | $64K |
| 90647 | <1% | 4,202 | $62K | |
| 90723 | <1% | 4,167 | $62K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 13,341 | $60K |
| 90651 | <1% | 2,884 | $58K | |
| 90715 | <1% | 2,265 | $55K | |
| 90633 | <1% | 3,038 | $53K | |
| 0001A | <1% | 1,236 | $52K | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 1,976 | $50K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 4,839 | $49K |
| 0012A | <1% | 1,589 | $47K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,011 | $44K |
| 0002A | <1% | 1,083 | $44K | |
| D4341 | <1% | 737 | $43K | |
| 0011A | <1% | 1,556 | $40K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,399 | $39K |
| D4342 | <1% | 795 | $39K | |
| 91320 | <1% | 527 | $37K | |
| 90680 | <1% | 2,321 | $32K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 2,381 | $30K |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 2,317 | $29K |
| 87428 | <1% | 1,529 | $27K | |
| 0072A | <1% | 673 | $27K | |
| 90734 | <1% | 1,136 | $25K | |
| 0071A | <1% | 589 | $24K | |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 394 | $23K |
| 97802 | <1% | 3,748 | $20K | |
| 90656 | <1% | 893 | $19K | |
| 90671 | <1% | 801 | $19K | |
| 90710 | <1% | 903 | $19K | |
| 99205 | Prolong outpt/office vis | <1% | 453 | $19K |
| 90480 | <1% | 643 | $19K | |
| 90700 | <1% | 827 | $17K | |
| 90672 | <1% | 887 | $17K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 979 | $16K |
| 90732 | <1% | 182 | $16K | |
| 91322 | <1% | 220 | $15K | |
| 0124A | <1% | 370 | $15K | |
| 99383 | <1% | 129 | $14K | |
| 96160 | <1% | 5,872 | $13K | |
| D0273 | <1% | 1,158 | $12K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 286 | $11K |
| 0013A | <1% | 299 | $10K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,529 | $10K |
| 90696 | <1% | 497 | $10K | |
| 90681 | <1% | 589 | $10K | |
| 90658 | <1% | 613 | $9K | |
| 99442 | <1% | 3,252 | $8K | |
| 0031A | <1% | 315 | $8K | |
| D0270 | <1% | 1,802 | $8K | |
| 98968 | <1% | 257 | $8K | |
| 83655 | <1% | 1,397 | $8K | |
| 0003A | <1% | 191 | $7K | |
| 98967 | <1% | 204 | $7K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 461 | $7K |
| 90685 | <1% | 309 | $7K | |
| 90716 | <1% | 390 | $6K | |
| 90619 | <1% | 268 | $6K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 158 | $6K |
| 99441 | <1% | 2,259 | $5K | |
| 99460 | <1% | 149 | $5K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 281 | $5K |
| 90707 | <1% | 305 | $5K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 196 | $5K |
| 90713 | <1% | 243 | $4K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 156 | $4K |
| 90660 | <1% | 158 | $3K | |
| 90648 | <1% | 205 | $3K | |
| 90677 | <1% | 154 | $3K | |
| 90673 | <1% | 62 | $3K | |
| 90661 | <1% | 144 | $3K | |
| 90662 | <1% | 249 | $3K | |
| 96152 | <1% | 91 | $3K | |
| 96158 | <1% | 81 | $3K | |
| 85018 | <1% | 3,284 | $3K | |
| 99381 | <1% | 80 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 246 | $2K |
| 99443 | <1% | 618 | $2K | |
| D2331 | <1% | 34 | $2K | |
| 0111A | <1% | 43 | $2K | |
| 99385 | <1% | 13 | $2K | |
| 99384 | <1% | 12 | $2K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 153 | $2K |
| G0467 | Community health center visit, returning patient | <1% | 1,234 | $2K |
| 91321 | <1% | 74 | $1K | |
| 0134A | <1% | 63 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 144 | $1K |
| 0054A | <1% | 31 | $1K | |
| 90649 | <1% | 40 | $1K | |
| D2330 | <1% | 32 | $1K | |
| 90620 | <1% | 17 | $1K | |
| 0074A | <1% | 25 | $1K | |
| 90697 | <1% | 44 | $966.24 | |
| 0154A | <1% | 25 | $960.00 | |
| 0052A | <1% | 24 | $920.00 | |
| 0053A | <1% | 25 | $907.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 306 | $857.52 |
| 97803 | <1% | 301 | $769.81 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 533 | $712.17 |
| 0051A | <1% | 18 | $680.00 | |
| 92551 | <1% | 170 | $658.54 | |
| 99382 | <1% | 65 | $628.36 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 136 | $544.78 |
| 0112A | <1% | 13 | $520.00 | |
| G0008 | Administration of influenza virus vaccine | <1% | 356 | $487.23 |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 15 | $401.96 |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | <1% | 43 | $378.00 |
| 90381 | <1% | 16 | $351.36 | |
| 90744 | <1% | 13 | $285.48 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 44 | $222.33 |
| 99408 | <1% | 18 | $209.26 | |
| 99459 | <1% | 28 | $207.96 | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 16 | $130.80 |
| 97804 | <1% | 137 | $126.30 | |
| 99462 | <1% | 14 | $109.38 | |
| 96127 | <1% | 13 | $67.34 | |
| 96153 | <1% | 55 | $38.93 | |
| 81002 | <1% | 209 | $34.64 | |
| 99188 | <1% | 12 | $25.94 | |
| D0603 | <1% | 11,477 | $25.00 | |
| D0601 | <1% | 1,562 | $21.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 13 | $14.26 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 197 | $13.39 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 15 | $0.98 |
| 3078F | 0% | 29,764 | $0.00 | |
| 3077F | 0% | 4,401 | $0.00 | |
| 0502F | 0% | 1,224 | $0.00 | |
| 91300 | 0% | 2,051 | $0.00 | |
| 82948 | 0% | 31 | $0.00 | |
| 3051F | 0% | 62 | $0.00 | |
| 3046F | 0% | 128 | $0.00 | |
| 81025 | 0% | 16 | $0.00 | |
| 3044F | 0% | 5,882 | $0.00 | |
| 3074F | 0% | 32,191 | $0.00 | |
| 3075F | 0% | 4,853 | $0.00 | |
| 3079F | 0% | 10,209 | $0.00 | |
| 3052F | 0% | 38 | $0.00 | |
| D0602 | 0% | 2,653 | $0.00 | |
| 91301 | 0% | 2,626 | $0.00 | |
| 3080F | 0% | 1,082 | $0.00 | |
| D3120 | 0% | 559 | $0.00 | |
| 91303 | 0% | 251 | $0.00 | |
| 86580 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTROTTER, CHRISTINE (CHIEF EXECUTIVE OFFICIER)
Parent organizationYAKIMA VALLEY FARM WORKERS CLINIC
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.